BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 29885994)

  • 1. Bevacizumab Monotherapy Reduces Radiation-induced Brain Necrosis in Nasopharyngeal Carcinoma Patients: A Randomized Controlled Trial.
    Xu Y; Rong X; Hu W; Huang X; Li Y; Zheng D; Cai Z; Zuo Z; Tang Y
    Int J Radiat Oncol Biol Phys; 2018 Aug; 101(5):1087-1095. PubMed ID: 29885994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Variables for Prediction of the Therapeutic Effects of Bevacizumab Monotherapy in Nasopharyngeal Carcinoma Patients With Radiation-Induced Brain Necrosis.
    Li Y; Huang X; Jiang J; Hu W; Hu J; Cai J; Rong X; Cheng J; Xu Y; Wu R; Luo J; Tang Y
    Int J Radiat Oncol Biol Phys; 2018 Mar; 100(3):621-629. PubMed ID: 29413276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bevacizumab for radiation necrosis following radiotherapy of brain metastatic disease: a systematic review & meta-analysis.
    Khan M; Zhao Z; Arooj S; Liao G
    BMC Cancer; 2021 Feb; 21(1):167. PubMed ID: 33593308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison between high-dose and low-dose intravenous methylprednisolone therapy in patients with brain necrosis after radiotherapy for nasopharyngeal carcinoma.
    Zhuo X; Huang X; Yan M; Li H; Li Y; Rong X; Lin J; Cai J; Xie F; Xu Y; Chen K; Tang Y
    Radiother Oncol; 2019 Aug; 137():16-23. PubMed ID: 31048233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bevacizumab Combined with Corticosteroids Does Not Improve the Clinical Outcome of Nasopharyngeal Carcinoma Patients With Radiation-Induced Brain Necrosis.
    Li H; Rong X; Hu W; Yang Y; Lei M; Wen W; Yue Z; Huang X; Chua MLK; Li Y; Cai J; He L; Pan D; Cheng J; Pi Y; Xue R; Xu Y; Tang Y
    Front Oncol; 2021; 11():746941. PubMed ID: 34650930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bevacizumab as a treatment for radiation necrosis of brain metastases post stereotactic radiosurgery.
    Boothe D; Young R; Yamada Y; Prager A; Chan T; Beal K
    Neuro Oncol; 2013 Sep; 15(9):1257-63. PubMed ID: 23814264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Systematic Review Informing the Management of Symptomatic Brain Radiation Necrosis After Stereotactic Radiosurgery and International Stereotactic Radiosurgery Society Recommendations.
    Vellayappan B; Lim-Fat MJ; Kotecha R; De Salles A; Fariselli L; Levivier M; Ma L; Paddick I; Pollock BE; Regis J; Sheehan JP; Suh JH; Yomo S; Sahgal A
    Int J Radiat Oncol Biol Phys; 2024 Jan; 118(1):14-28. PubMed ID: 37482137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized double-blind placebo-controlled trial of bevacizumab therapy for radiation necrosis of the central nervous system.
    Levin VA; Bidaut L; Hou P; Kumar AJ; Wefel JS; Bekele BN; Grewal J; Prabhu S; Loghin M; Gilbert MR; Jackson EF
    Int J Radiat Oncol Biol Phys; 2011 Apr; 79(5):1487-95. PubMed ID: 20399573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of cerebral radiation necrosis with bevacizumab: the Cleveland clinic experience.
    Sadraei NH; Dahiya S; Chao ST; Murphy ES; Osei-Boateng K; Xie H; Suh JH; Peereboom DM; Stevens GH; Ahluwalia MS
    Am J Clin Oncol; 2015 Jun; 38(3):304-10. PubMed ID: 23799286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single low-dose targeted bevacizumab infusion in adult patients with steroid-refractory radiation necrosis of the brain: a phase II open-label prospective clinical trial.
    Dashti SR; Kadner RJ; Folley BS; Sheehan JP; Han DY; Kryscio RJ; Carter MB; Shields LBE; Plato BM; La Rocca RV; Spalding AC; Yao TL; Fraser JF
    J Neurosurg; 2022 Dec; 137(6):1676-1686. PubMed ID: 35426830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood-Brain Barrier Repair of Bevacizumab and Corticosteroid as Prediction of Clinical Improvement and Relapse Risk in Radiation-Induced Brain Necrosis: A Retrospective Observational Study.
    Xue R; Chen M; Cai J; Deng Z; Pan D; Liu X; Li Y; Rong X; Li H; Xu Y; Shen Q; Tang Y
    Front Oncol; 2021; 11():720417. PubMed ID: 34692494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploration of the recurrence in radiation brain necrosis after bevacizumab discontinuation.
    Zhuang H; Yuan X; Chang JY; Song Y; Wang J; Yuan Z; Wang X; Wang P
    Oncotarget; 2016 Jul; 7(30):48842-48849. PubMed ID: 26934327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of edaravone on radiation-induced brain necrosis in patients with nasopharyngeal carcinoma after radiotherapy: a randomized controlled trial.
    Tang Y; Rong X; Hu W; Li G; Yang X; Yang J; Xu P; Luo J
    J Neurooncol; 2014 Nov; 120(2):441-7. PubMed ID: 25142813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bevacizumab in the treatment of radiation injury for children with central nervous system tumors.
    Dahl NA; Liu AK; Foreman NK; Widener M; Fenton LZ; Macy ME
    Childs Nerv Syst; 2019 Nov; 35(11):2043-2046. PubMed ID: 31367784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Temporal Cerebral Microbleeds Are Associated With Radiation Necrosis and Cognitive Dysfunction in Patients Treated for Nasopharyngeal Carcinoma.
    Shen Q; Lin F; Rong X; Yang W; Li Y; Cai Z; Xu P; Xu Y; Tang Y
    Int J Radiat Oncol Biol Phys; 2016 Apr; 94(5):1113-20. PubMed ID: 27026315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laser interstitial thermal therapy (LITT) vs. bevacizumab for radiation necrosis in previously irradiated brain metastases.
    Sujijantarat N; Hong CS; Owusu KA; Elsamadicy AA; Antonios JP; Koo AB; Baehring JM; Chiang VL
    J Neurooncol; 2020 Jul; 148(3):641-649. PubMed ID: 32602021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bevacizumab as an effective treatment for radiation necrosis after radiotherapy for melanoma brain metastases.
    Glitza IC; Guha-Thakurta N; D'Souza NM; Amaria RN; McGovern SL; Rao G; Li J
    Melanoma Res; 2017 Dec; 27(6):580-584. PubMed ID: 28817446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bevacizumab alleviates radiation-induced brain necrosis: A report of four cases.
    Xiang-Pan L; Yuxin C; Xiao-Fei W; Na L; Tang-Peng X; Xiao-Tao X; Chang-Li R; Wei-Guo H; Qi-Bin S
    J Cancer Res Ther; 2015; 11(2):485-7. PubMed ID: 26148625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bevacizumab biosimilar BEVZ92 versus reference bevacizumab in combination with FOLFOX or FOLFIRI as first-line treatment for metastatic colorectal cancer: a multicentre, open-label, randomised controlled trial.
    Romera A; Peredpaya S; Shparyk Y; Bondarenko I; Mendonça Bariani G; Abdalla KC; Roca E; Franke F; Melo Cruz F; Ramesh A; Ostwal V; Shah P; Rahuman SA; Paravisini A; Huerga C; Del Campo García A; Millán S
    Lancet Gastroenterol Hepatol; 2018 Dec; 3(12):845-855. PubMed ID: 30262136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bevacizumab Treatment of Radiation-Induced Brain Necrosis: A Systematic Review.
    Liao G; Khan M; Zhao Z; Arooj S; Yan M; Li X
    Front Oncol; 2021; 11():593449. PubMed ID: 33842309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.